Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation

American Journal of Transplantation

Volumn 10, Issue 3, 2010, Pages 582-589

  Gloor, J M ^a   Winters, J L ^b   Cornell, L D ^b   Fix, L A ^b   Degoey, S R ^b   Knauer, R M ^b   Cosio, F G ^a   Gandhi, M J ^b   Kremers, W ^b   Stegall, M D ^b  

^a Transplant Center   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Antibody mediated rejection; Donor specific antibody; Kidney transplantation; Positive crossmatch; Transplant glomerulopathy

Indexed keywords

ALLOANTIBODY; HLA ANTIBODY; ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; FEMALE; GLOMERULOPATHY; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; BIOPSY; COHORT ANALYSIS; DONOR; GRAFT REJECTION; HISTOCOMPATIBILITY TEST; IMMUNOLOGY; KIDNEY DISEASES; MIDDLE AGED; PROCEDURES; RETROSPECTIVE STUDY; RISK; TREATMENT OUTCOME;

ADULT; ANTIBODIES; BIOPSY; COHORT STUDIES; FEMALE; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK; TISSUE DONORS; TREATMENT OUTCOME;

EID: 76949086210     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02985.x     Document Type: Article

References (17)

1. Jordan SC, Vo A, Bunnapradist S et al. Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients. Transplantation 2003 76 : 631 636.
2. Schweitzer E, Wilson JS, Fernandez-Vina M et al. A high panel-reactive antibody rescue protocol for cross-match-positive live donor kidney transplants. Transplantation 2000 70 : 1531 1536.
3. Montgomery R, Zachary AA, Racusen LC et al. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation 2000 70 : 887 895.
4. Gloor JM, DeGoey SR, Pineda AA et al. Overcoming a positive crossmatch in living donor kidney transplantation. Am J Transplant 2003 3 : 1017 1023.
5. Glotz D, Antoine C, Julia P et al. Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulin. Am J Transplant 2002 2 : 758 760.
6. Gebel H, Bray R. Sensitization and sensitivity: Defining the unsensitized patient. Transplantation 2000 69 : 1370 1374.
7. Pei R, Lee J-H, Chen T et al. Flow cytometeric detection of HLA antibodies using a spectrum of microbeads. Human Immunol 1999 60 : 1293 1302.
8. Pei R, Lee J-H, Shih N-J et al. Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities. Transplantation 2003 75 : 43 49.
9. Gloor JM, DeGoey SR, Ploeger NA et al. Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation. Transplantation 2004 78 : 221 227.
10. Burns JM, Cornell LD, Perry DK et al. Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation. Am J Transplant 2008 8 : 2684 2694.
11. Stegall MD, Gloor JM, Winters JL et al. A comparison of plasmapheresis vs. high dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody. Am J Transplant 2006 6 : 346 351.
12. Racusen LC, Colvin RB, Solez K et al. Antibody-mediated rejection criteria - An addition to the Banff '97 classification of renal allograft rejection. Am J Transplant 2003 3 : 708 714.
13. Gloor JM, Sethi S, Stegall MD et al. Transplant glomerulopathy: Subclinical incidence and association with alloantibody. Am J Transplant 2007 7 : 2124 2132.
14. Thielke J, West-Thielke PM, Herren HL et al. Living donor kidney transplantation across positive crossmatch: The University of Illinois at Chicago experience. Transplantation 2009 87 : 268 273.
15. Gloor JM, Cosio FG, Rea D et al. Histologic findings one year after positive crossmatch or ABO blood group incompatible living donor kidney transplantation. Am J Transplant 2006 6 : 1841 1847.
16. Akalin E, Dinavahi R, Friedlander R et al. The addition of plasmapheresis decreases the incidence of acute antibody-mediated rejection in sensitized patients with strong donor specific antibodies. Clin J Am Soc Nephrol 2008 3 : 1160 1167.
17. McCullogh KP, Keith DS, Meyer KH et al. Kidney and pancreas transplantation in the United States, 1998-2007: Access for patients with diabetes and end-stage renal disease. Am J Transplant 2009 9 : 894 906.